ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $656,000 | -29.8% | 16,245 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $935,000 | -3.1% | 16,245 | +7.3% | 0.00% | 0.0% |
| Q1 2015 | $965,000 | +442.1% | 15,145 | +482.5% | 0.00% | +300.0% |
| Q4 2014 | $178,000 | +790.0% | 2,600 | +356.1% | 0.00% | – |
| Q2 2014 | $20,000 | +5.3% | 570 | +32.6% | 0.00% | – |
| Q1 2014 | $19,000 | -77.6% | 430 | -79.8% | 0.00% | – |
| Q4 2013 | $85,000 | +13.3% | 2,126 | +6.2% | 0.00% | – |
| Q3 2013 | $75,000 | – | 2,002 | -3.7% | 0.00% | – |
| Q2 2013 | $0 | – | 2,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |